Santhosh Kalash Rajendrakumar

Dr. Santhosh Kalash Rajendrakumar

University of Warwick, Coventry, UK
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2018 in Biomacromolecules
Verified
Journal Article
Closed access
Santhosh Kalash RajendrakumarSanthosh Kalash Rajendrakumar
Santhosh Kalash Rajendrakumar
SUSaji uthaman
Saji uthaman
CCChong-Su Cho
Chong-Su Cho
IPIn-Kyu Park
In-Kyu Park

24 September 2018 in Nano Letters
Verified
Journal Article
Closed access
Santhosh Kalash RajendrakumarSanthosh Kalash Rajendrakumar
Santhosh Kalash Rajendrakumar
VRVishnu Revuri
Vishnu Revuri
MSManikandan Samidurai
Manikandan Samidurai
AMAdityanarayan Mohapatra
Adityanarayan Mohapatra
JLJae Hyuk Lee
Jae Hyuk Lee
IPIn-Kyu Park
In-Kyu Park

20 September 2021 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
VRVishnu Revuri
Vishnu Revuri
Santhosh Kalash RajendrakumarSanthosh Kalash Rajendrakumar
Santhosh Kalash Rajendrakumar
MPMyong‐Suk Park
Myong‐Suk Park
AMAdityanarayan Mohapatra
Adityanarayan Mohapatra
SUSaji uthaman
Saji uthaman
YLYong-kyu Lee
Yong-kyu Lee

Verified
Journal Article
Open access
PDF file
Santhosh Kalash RajendrakumarSanthosh Kalash Rajendrakumar
Santhosh Kalash Rajendrakumar
NCNing-Chu Chang
Ning-Chu Chang
AMAdityanarayan Mohapatra
Adityanarayan Mohapatra
SUSaji uthaman
Saji uthaman
BLByeong-il Lee
Byeong-il Lee
IPIn-Kyu Park
In-Kyu Park
To prolong blood circulation and avoid the triggering of immune responses, nanoparticles in the bloodstream require conjugation with polyethylene glycol (PEG). However, PEGylation hinders the interaction between the nanoparticles and the tumor cells and therefore limits the applications of PEGylated nanoparticles for therapeutic drug delivery. To overcome this limitation, zwitterionic materials can be used to enhance the systemic blood circulation and tumor-specific delivery of hydrophobic agents such as IR-780 iodide dye for photothermal therapy. Herein, we developed micellar nanoparticles using the amphiphilic homopolymer poly(12-(methacryloyloxy)dodecyl phosphorylcholine) (PCB-lipid) synthesized via reversible addition–fragmentation chain transfer (RAFT) polymerization. The PCB-lipid can self-assemble into micelles and encapsulate IR-780 dye (PCB-lipid–IR-780). Our results demonstrated that PCB-lipid–IR-780 nanoparticle (NP) exhibited low cytotoxicity and remarkable photothermal cytotoxicity to cervical cancer cells (TC-1) upon near-infrared (NIR) laser irradiation. The biodistribution of PCB-lipid–IR-780 showed higher accumulation of PCB-lipid–IR-780 than that of free IR-780 in the TC-1 tumor. Furthermore, following NIR laser irradiation of the tumor region, the PCB-lipid–IR-780 accumulated in the tumor facilitated enhanced tumor ablation and subsequent tumor regression in the TC-1 xenograft model. Hence, these zwitterionic polymer-lipid hybrid micellar nanoparticles show great potential for cancer theranostics and might be beneficial for clinical applications.

1 April 2018 in Journal of Controlled Release
Verified
Journal Article
Closed access
Santhosh Kalash RajendrakumarSanthosh Kalash Rajendrakumar
Santhosh Kalash Rajendrakumar
Kondareddy CherukulaKondareddy Cherukula
Kondareddy Cherukula
HPHyeong Ju Park
Hyeong Ju Park
SUSaji uthaman
Saji uthaman
YJYong Yeon Jeong
Yong Yeon Jeong
IPIn-Kyu Park
In-Kyu Park

16 January 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
AMAdityanarayan Mohapatra
Adityanarayan Mohapatra
Santhosh Kalash RajendrakumarSanthosh Kalash Rajendrakumar
Santhosh Kalash Rajendrakumar
GCGopalakrishnan Chandrasekaran
Gopalakrishnan Chandrasekaran
VRVishnu Revuri
Vishnu Revuri
PSPadmanaban Sathiyamoorthy
Padmanaban Sathiyamoorthy
IPIn-Kyu Park
In-Kyu Park